|
ZNF30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.688100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.510200E-02 |
| Normal-vs-Stage2 |
4.765200E-01 |
| Normal-vs-Stage3 |
5.413900E-02 |
| Normal-vs-Stage4 |
9.355000E-04 |
| Stage1-vs-Stage2 |
1.030110E-02 |
| Stage1-vs-Stage3 |
6.809400E-01 |
| Stage1-vs-Stage4 |
5.074200E-02 |
| Stage2-vs-Stage3 |
1.405900E-02 |
| Stage2-vs-Stage4 |
6.582500E-04 |
| Stage3-vs-Stage4 |
1.432010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.376100E-03 |
| Normal-vs-AfricanAmerican |
2.790200E-02 |
| Normal-vs-Asian |
8.830600E-01 |
| Caucasian-vs-AfricanAmerican |
6.567000E-01 |
| Caucasian-vs-Asian |
8.822600E-03 |
| AfricanAmerican-vs-Asian |
4.285500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.160800E-01 |
| Normal-vs-Female |
9.564100E-03 |
| Male-vs-Female |
1.119530E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.033800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.046000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.986400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.997200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.496600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.114300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.848000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.067240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.314800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.210800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.834200E-02 |
| Classical-VS-Follicular |
6.23579999999846E-05 |
| Classical-VS-Other |
7.477600E-01 |
| Classical-VS-Normal |
1.494150E-02 |
| Tall-VS-Follicular |
3.15470000000762E-06 |
| Tall-VS-Other |
1.925170E-01 |
| Tall-VS-Normal |
1.043020E-03 |
| Follicular-VS-Other |
3.008800E-01 |
| Follicular-VS-Normal |
2.434200E-01 |
| Other-VS-Normal |
4.809800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.071200E-01 |
| Normal-vs-N1 |
2.838100E-03 |
| N0-vs-N1 |
3.744700E-03 |
|
|
